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INTRODUCTION
The purpose of total-body irradiation (TBI) and allo-
geneic marrow transplantation for the therapy of patients
with leukemia is to deliver the greatest antileukemic and
immunosuppressive effects with the least toxicity to non-
hematopoietic organs. Variables influencing the effect of TBI
include total radiation dose, dose rate, and fractionation. The
issue of dose rate effects on hematopoietic cells has been
controversial. Some investigators have concluded that
increasing the dose rate increases the death rate of hemato-
poietic cells at a given total dose of TBI [1–3], although for
smaller total doses (e.g., 200 cGy), it has been assumed that
there is little dose-rate effect because most cell killing would
be effected by single-hit mechanisms [4]. Other investigators
maintain that there are no significant differences in radiation
sensitivity of hematopoietic cells at different dose rates [5–9].
The issue of dose fractionation of TBI has also been
controversial. Some investigators have advanced the concept
that hematopoietic cells have a lessened ability for DNA
repair in interfraction intervals than cells from other organs,
and that the effect on the marrow would be similar for a
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ABSTRACT
We evaluated the marrow toxicity of 200 and 300 cGy total-body irradiation (TBI) delivered at 10 and 60 cGy/min,
respectively, in dogs not rescued by marrow transplant. Additionally, we compared toxicities after 300 cGy fraction-
ated TBI (100 cGy fractions) to that after single-dose TBI at 10 and 60 cGy/min. Marrow toxicities were assessed
on the basis of peripheral blood cell count changes and mortality from radiation-induced pancytopenia. TBI doses
studied were just below the dose at which all dogs die despite optimal support. Specifically, 18 dogs were given sin-
gle doses of 200 cGy TBI, delivered at either 10 (n513) or 60 (n55) cGy/min. Thirty-one dogs received 300 cGy
TBI at 10 cGy/min, delivered as either single doses (n521) or three fractions of 100 cGy each (n510). Seventeen
dogs were given 300 cGy TBI at 60 cGy/min, administered either as single doses (n55) or three fractions of 100
cGy each (n510). Within the limitations of the experimental design, three conclusions were drawn: 1) with 200 and
300 cGy single-dose TBI, an increase of dose rate from 10 to 60 cGy/min, respectively, caused significant increases
in marrow toxicity; 2) at 60 cGy/min, dose fractionation resulted in a significant decrease in marrow toxicities,
whereas such a protective effect was not seen at 10 cGy/min; and 3) with fractionated TBI, no significant differences
in marrow toxicity were seen between dogs irradiated at 60 and 10 cGy/min. The reduced effectiveness of TBI
when a dose of 300 cGy was divided into three fractions of 100 cGy or when dose rate was reduced from 60
cGy/min to 10 cGy/min was consistent with models of radiation toxicity that allow for repair of sublethal injury in
DNA.
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given total dose of single-dose or fractionated TBI [10–15].
Others have disputed this view and have presented data to
the effect that malignant and nonmalignant hematopoietic
cells have greater repair capacity than previously thought and
believe that a single dose of TBI delivered at the relatively
high dose rate of 26 cGy may achieve better leukemic cell
kill than fractionated TBI [16–18]. The controversy may be
related to the mixture of different cell types that make up the
hematopoietic system, which have a wide range of radiation
sensitivities, and to different experimental readouts depend-
ing on which cells were studied for irradiation effects.
Given the controversies, it is not surprising that a wide
spectrum of TBI conditioning programs has been developed
clinically. Programs range from single-dose 500 cGy at 50
cGy/min to almost 1600 cGy at 6–7 cGy/min given in seven
fractions over 7 days [19–23]. Other regimens have included
hyperfractionation with up to 12 fractions administered over
3 days [24].
Early attempts at mathematical description of how deliv-
ery method affects the potency of a radiation dose focused
either on varying dose rate for a single, continuous exposure
or on varying the number and separation of fractions given
in acute bursts. Nilsson et al. [25] generalized from these
models and developed an equation describing the surviving
fraction of a cell population exposed to radiation when there
is exponential repair of sublethally damaged cells both dur-
ing and between radiation fractions. In their model, the
effect of a given dose of radiation depends on the number of
fractions, the exposure time for each fraction, and the inter-
fraction interval. It follows from their mathematical expres-
sion that switching from a single session to a fractionated
delivery schedule boosts cell survival most when radiation is
given in acute bursts. As the dose rate decreases, fractiona-
tion yields diminishing gain in cell survival for the same total
dose [25,26]. Presumably, during the relatively long exposure
times needed to deliver single-dose TBI at low dose rates,
the “four R’s of radiobiology” [14], reassortment, repopula-
tion, reoxygenation, and recovery (DNA repair), become
operative, perhaps changing the radiosensitivity of cells. 
We have addressed many of the issues associated with
TBI in dogs with the aim of developing clinically applicable
TBI programs [27–34]. Initial studies were all done with
dose rates of ≤10 cGy/min. The marrow-lethal single dose
was found to be 400 cGy [27]. When we compared the mar-
row-toxic effects of single-dose vs. fractionated TBI with
total doses ranging from 200 to 600 cGy, we could find no
statistically significant differences in the marrow toxicity
between the two modes of radiation, even when dogs were
treated with canine recombinant granulocyte colony-stimu-
lating factor (rG-CSF) after TBI [27]. 
Given the previous findings, the current study explored
marrow toxicity of fractionated vs. single-dose TBI deliv-
ered at the relatively high dose rate of 60 cGy/min. Total
TBI doses of 200 and 300 cGy were studied in dogs not
given marrow infusions, and results were compared with
those at a dose rate of 10 cGy/min. 
MATERIALS AND METHODS
Beagles and hound/beagle and beagle/harrier cross-
breeds were raised at the Fred Hutchinson Cancer Research
Center or purchased from commercial kennels in Washing-
ton State. The dogs weighed 6.2–19.7 kg (median 9.9) and
were 5.5–17.5 months of age (median 7.8). They were
observed for disease for at least 2 months before TBI. All
were immunized for leptospirosis, hepatitis, distemper, and
parvovirus. Research was carried out according to the prin-
ciples in the Guide for Laboratory Animal Facilities and Care
prepared by the National Academy of Sciences, National
Research Council. The research protocol was approved by
the Institutional Animal Care and Use Committee of the
Fred Hutchinson Cancer Research Center.
TBI was administered to the unanesthetized dogs
housed in a polyurethane cage placed transversely midway
between two opposing 60Co sources as previously described
[27,32,33]. Beam intensity over the entire cross-sectional
area of the cage was .90% of the central axis intensity.
The dose rate in air at the midpoint of the cage was deter-
mined with a 0.6 cm3 ionization chamber (Keithley Instru-
ments, Cleveland, OH) and an electrometer system (Keith-
ley Instruments). The midplane tissue absorbed dose in
grays, as measured by implanted lithium fluoride thermo-
luminescent dosimeters, was numerically ~76% of the
exposure in air at the center of the cage measured in roent-
gens. The midplane dose rate was either 10 or 60
cGy/min. The thermoluminescent dosimeters contained
lithium fluoride phosphor in disks (Teflon) and were meas-
ured with a reader (Teledyne Isotopes, Westwood, NJ) cal-
ibrated over a range of 1–50 Gy. Results in dogs given 300
cGy single-dose TBI were compared with those in dogs
given 300 cGy TBI administered in three 100-cGy frac-
tions. The time elapsed from the first to the third fraction
was ≤20 hours, with the first fraction separated from the
second by a minimum of 6 hours. 
Dogs were given oral neomycin sulfate and polymyxin
B sulfate three times a day beginning 5 days before TBI
through the day after transplant at which granulocyte
counts reached 500/mm3 [35]. Additionally, they were
treated twice a day with systemic ceftazidime until granu-
locyte recovery. Platelet transfusions from unrelated
donors were given when platelet counts fell  to
,5000/mm3. Hemorrhage was not a serious problem in
the study. All transfusions were irradiated in vitro with
2000 cGy from a 137Ce source to inactivate lymphocytes.
Complete peripheral blood cell counts, including white
blood cell differentials, were obtained daily between 8 and
9 a.m. All dogs that died or were killed with sodium pento-
barbital had complete autopsies with histologic examina-
tion of autopsy specimens.
We assessed the marrow toxicity of each treatment on
the basis of survival and individual dogs’ peripheral blood
granulocyte and platelet count changes through time after
TBI. All tests concerning proportions of dogs that survived
with complete hematologic recovery were conducted using
small-sample testing procedures based on Monte Carlo sim-
ulation [36]. Blood counts were summarized by plotting
median counts among surviving dogs. Group medians were
calculated only while at least three dogs survived in the
group, and medians were connected in the plots using a
spline smoothing technique with Stata statistical software
[37]. We tested for differences between groups in the nadir
blood counts using Wilcoxon rank-sum tests. 
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RESULTS
Tables 1 and 2 and Figures 1–3 summarize the results.
Data on the 44 dogs that received TBI at 10 (n535) or 7
(n59) cGy/min have been published previously [27] and are
presented here for purposes of comparison.
Five dogs were given a single dose of 200 cGy TBI
delivered at 60 cGy/min. Their peripheral blood platelet
and granulocyte counts showed significantly lower nadirs (p
5 0.01 and 0.02, respectively) than those of 13 dogs given
200 cGy TBI at 10 cGy/min (Fig. 1). Lymphocyte counts
also declined more in dogs given TBI at the higher dose
rate, although the difference did not reach statistical signifi-
cance (p 5 0.055). Four of the five dogs given 200 cGy at 60
cGy/min survived, compared with 12 of 13 given the same
dose of TBI at 10 cGy/min, a difference that was not statis-
tically significant. Fractionated TBI was not studied at 200
cGy because of the almost uniform survival of dogs given
single-dose TBI, regardless of the dose rates studied.
Forty-six dogs were given 300 cGy TBI. The dose of
300 cGy was deemed to be most informative, since previous
studies had shown it not to be uniformly lethal (30% [single
dose] and 60% [fractionated dose] of dogs so treated sur-
vived), while after 400 cGy, virtually all dogs (27 of 28) died
[27]. In 21 of the dogs given 300 cGy, single-dose TBI was
administered at low dose rates (10 cGy/min, n=12; 7
cGy/min, n=9), and in five dogs it was administered at 60
cGy/min. Seven of the 21 dogs given single-dose TBI at a
low dose rate survived, compared with none of five given
single-dose TBI at 60 cGy/min, a result that was not signifi-
cantly different (p 5 0.14). 
Twenty dogs received 300 cGy fractionated TBI. Six of
10 dogs given TBI at 10 cGy/min survived compared with
seven of 10 at 60 cGy/min (p 5 0.82). When comparing
survival of dogs given single-dose TBI at 10 cGy/min to
that of dogs given fractionated TBI at 10 cGy/min, no
significant difference emerged (p 5 0.18). Dogs given frac-
tionated TBI at 60 cGy/min, however, had significantly
better survival than those given single-dose TBI at 60
cGy/min (p 5 0.01). 
Table 1. Marrow toxicity of total body irradiation (TBI) given at 10 vs. 60
cGy/min
Total TBI Dose rate Dogs surviving/dogs studied
dose (cGy) (cGy/min) Single dose Fractionated
200* 10 12/13† —
200 60 4/5 —
300* 10‡ 7/21 6/10
300 60 0/5 7/10
p values derived from Monte Carlo simulation tests.
*Data on these dogs previously published [16].
†p = 0.53 vs. dogs given a single dose of 200 cGy at 60 cGy/min.
‡Nine of the 21 dogs received 7 cGy/min; six of those nine died compared with
eight of 12 receiving 10 cGy/min.
Table 2. Dogs given 200 or 300 cGy total body irradiation from two opposing 60Co sources, delivered at 60 cGy/min in a single dose or three fractions of 100 cGy
each over 2 days with <6-hour interfraction intervals
Granulocyte Marrow cellularity 
Total Mode of Dose rate recovery after at autopsy Survival Cause of 
Dog no. dose (cGy) radiation (cGy/min) postirradiation nadir (% normal) (days)* death
D273 200 Single dose 60 Yes 100 65‡ Killed†
D286 Yes 100 77‡ Killed†
D348 Yes 100 64‡ Killed†
D349 Yes 100 63‡ Killed†
D325 No ,5 19 Septicemia
D203 300 Single dose 60 No ,5 18 Pneumonia
D344 No 0 20 Septicemia
D408 No 0 17 Septicemia
D409 No 0 19 Pneumonia
D421 No ,5 20 Septicemia
D378 300 33100 cGy 60 Yes 100 56‡ Killed†
D404 Yes 100 50‡ Killed†
D410 Yes 80 53‡ Killed†
D511 No 0 22 Septicemia
D517 Yes 100 40‡ Killed†
D521 No ,5 18 Septicemia
D523 Yes 100 60‡ Killed†
D531 Yes 100 75‡ Killed†
D533 No ,5 17 Septicemia
D538 Yes 100 72‡ Killed†
Dogs were not given marrow infusions. 
*Measured from time of last irradiation. 
†Killed with intravenous injection of sodium pentobarbital at the completion of the experiment. 
‡Dogs that survived with complete hematological recovery after TBI.
p = 0.53‡
p = 0.18





In addition to the preceding pairwise comparisons, we
performed a Monte Carlo simulation test to determine
whether the factor by which survival differed between sin-
gle and fractionated modes of TBI delivery was the same at
both 10 and 60 cGy/min. The result indicated that dose
rate had a significant impact on the differential between
effects of single and fractionated TBI (p 5 0.03), the
greater difference in survival occurring when the dose rate
was 60 cGy/min.
In dogs given 300 cGy single-dose or fractionated TBI,
there were strong indications that postirradiation platelet
counts fell to lower levels when the dose rate was 60
cGy/min compared with 10 cGy/min (p 5 0.06 single; p 5
0.03 fractionated) (Fig. 2). Granulocyte counts dropped very
low for dogs in all four groups receiving 300 cGy (Fig. 3).
There were no significant differences between granulocyte
nadirs from dogs irradiated at 10 vs. 60 cGy/min, with
either single-dose or fractionated TBI. Among dogs given
irradiation at 60 cGy/min, however, there was a weak sug-
gestion that those given single-dose TBI had lower periph-
eral blood granulocyte nadirs than those given fractionated
TBI (p 5 0.13), and the slope of the granulocyte counts in
dogs given single-dose TBI showed a significantly faster
decline (p 5 0.03). Regular daily peripheral blood counts
were not available for the nine dogs given 300 cGy at 7
cGy/min, so data from those animals could not be included
in the analyses of count nadirs.
DISCUSSION
The present study evaluated marrow toxicity of single-
dose vs. fractionated-dose TBI, delivered at the relatively
high dose rate of 60 cGy/min, based primarily on the crite-
ria of granulocyte and platelet changes and survival. Dogs
that died from marrow toxicity uniformly succumbed to
infections despite prophylaxis and treatment with oral and
systemic broad-spectrum antibiotics, infections presumably
being the direct result of the extent and duration of the radi-
ation-induced granulocytopenia. Thus, these results will
have to be viewed with the understanding that the model
addressed early radiation responses of a group of marrow
precursor cells that might correspond to murine spleen
colony-forming unit (CFU-S)–like cells. Damage to
pluripotent hematopoietic stem cells was not assessed here.
Using similar study criteria, we previously showed that
single-dose and fractionated TBI delivered at a dose rate of
10 cGy/min had marrow toxicities in this model comparable
to total doses of 200–600 cGy even when dogs were treated
after radiation with canine rG-CSF [27]. These findings fit
well with the concept that sublethal damage repair of
hematopoietic progenitor or stem cells was minimal during
fractionated radiation, with the result that the effects on
marrow of single vs. fractionated TBI delivered at the low
dose rate of 10 cGy/min were equivalent.
Two results emerged from the current study using a rel-
atively high dose rate of 60 cGy/min. First, a single dose of
TBI administered at 60 cGy/min appeared more marrow-
toxic than an equivalent total dose delivered at 10 cGy/min,
as indicated by more profound declines in peripheral blood
cell counts. Survival rates with single-dose delivery also
trended to show greater toxicity at the higher dose rate,
although the differences were not statistically significant.
This result agreed with those from a number of previous
studies in various model systems showing greater organ tox-
icity with higher dose rates [1,3,10–14,38–43]. In dogs, toxi-
city to both gut [34] and lymphoid system [44] increased
significantly when the TBI dose rate was increased by one
log. Interestingly, other studies, using transfer of marrow
cells from irradiated donors into irradiated recipients, found
no significant differences in radiation sensitivity of CFU-S
at different dose rates [5–7,9,45]. In one of those studies,
using day 9 CFU-S as an end point, the investigators irradi-
ated donor mice with TBI doses ranging from 100 to 500
cGy at dose rates of 8, 45, and 103 cGy/min [9]. They then
transplanted femoral marrow into lethally irradiated syn-
geneic recipient mice and found that the numbers of day 9
spleen colonies were identical, regardless of the dose rate
used to irradiate the marrow donors. One possible explana-
tion for the finding might be that the investigators killed
donor mice 24 hours after TBI, flushed the femurs, and
then adjusted the number of transplanted cells to yield
10–20 spleen colonies. This way, the experiment may have
been biased against radiation dose rate–dependent cell death
occurring over the 24 hours after TBI. Perhaps transplanta-
Figure 1. Peripheral blood platelet and granulocyte changes
Median peripheral blood platelet (A) and granulocyte (B) changes in dogs
given a single dose of 200 cGy TBI, delivered at 10 cGy/min (n513) or 60
cGy/min (n55). 1, 10 cGy/min; s, 60 cGy/min.
A
B
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tion of entire femur contents might have been another way
to address the question of dose rate–dependent radiation
toxicity of day 9 CFU-S. Nevertheless, in vitro irradiated
human and animal tumor cell lines also showed dose
rate–independent cell killing for almost all lines except
U937 and HL60 [8].
The second result was not anticipated from the previous
canine study [27]. Fractionated TBI delivered at 60 cGy/min
proved to be no more marrow-toxic than fractionated TBI
delivered at 10 cGy/min, but was significantly less toxic than
single-dose TBI at 60 cGy/min as determined within the lim-
itations of the current end points. Fractionated TBI at 10
Figure 2. Peripheral blood platelet changes
Dogs were given 300 cGy TBI, delivered at 10 cGy/min as a single dose (n510) or in three fractions (n510) or at 60 cGy/min as a single dose (n55) or in three
fractions (n510).
Figure 3. Peripheral blood granulocyte changes
Dogs were given 300 cGy TBI, delivered at 10 cGy/min as a single dose (n510) or in three fractions (n510) or at 60 cGy/min as a single dose (n55) or in three
fractions (n510).
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cGy/min was not significantly different from single-dose TBI
at 10 cGy/min. These results indicate that the mode of radia-
tion is an important factor in determining marrow toxicity.
The finding is consistent with DNA repair in those early
hematopoietic progenitor or stem cells during interfraction
intervals of high-dose-rate TBI that give rise to hemato-
poietic recovery. Furthermore, by inference, it can be argued
that such DNA repair is possible even during single-dose TBI
whenever the dose rate is low, such as 10 cGy or less. No
direct measurements of surviving fraction of hematopoietic
cell populations were available in the current, clinically ori-
ented experiments. It seems reasonable to expect, however,
that survival probability for the individual dog is closely and
directly linked to surviving fraction of hematopoietic cells.
Our statistical analyses of survival data suggest a different
impact of fractionating the total dose at high vs. low dose
rate. This result parallels the interactions between fractiona-
tion interval and dose rate that are described theoretically in
the generalized incomplete repair model of Nilsson et al. [25].
Current findings at high dose rate (single-dose TBI is
more marrow toxic than fractionated TBI) may help explain
the apparent discrepancy between our previous report (mar-
row toxicity of single-dose TBI at low dose rate equivalent to
that of fractionated TBI) and a report by Down et al. [1] in
congenic strains of mice differing for hemoglobin phenotype.
Consistent with the current findings, those authors reported
that full engraftment of congenic marrow occurred at 700
cGy single-dose TBI given at the high dose rate of 100
cGy/min, while it took 1600 cGy of fractionated TBI at the
same dose rate to achieve the same result. Ploemacher et al.
[17], using mice congenic for the glucose-phosphate iso-
merase gene, extended those observations and found that to
achieve the same level of engraftment seen with 4 Gy single-
dose TBI (dose rate 1.06–1.08 Gy/min), an extra 2 Gy of
fractionated TBI was needed. An earlier murine study had
already pointed out that the LD50–30 days dose of TBI increased
from 650 cGy given as a single fraction to 1200 cGy when
administered as five daily fractions [46]. Our own data on
engraftment of DLA-identical marrows also conclusively
showed that lymphoid cells, responsible for graft rejection,
were capable of DNA repair in interfraction intervals, and
much higher doses of fractionated than of single-dose TBI
were needed for consistent engraftment to occur [28,44].
Taken together, the murine and the current canine data
show that marrow toxicity of fractionated TBI is not always
equivalent to that of single-dose TBI. While extensive pre-
vious data from this laboratory describe no significant dif-
ferences between the two modes of radiation at low dose
rate, the current results at a relatively high dose rate show
that DNA repair in hematopoietic progenitor or stem cells
is possible during interfractionation intervals. Thus, frac-
tionated TBI at higher dose rates may have no advantage for
conditioning marrow graft recipients unless it can be shown
convincingly that the sparing of nonhematopoietic tissues
due to fractionation is significantly greater [31,47] than the
sparing of hematopoietic cells.
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